EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische Übersicht

Plant-derived therapies in Parkinson’s disease: a systematic review of clinical evidence

Narumol Sukmueng, Onanong Phokaewvarangkul, Roongroj Bhidayasiri iD

Journal of Neural Transmission · 23.07.2026

DOI: 10.1007/s00702-026-03239-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neural Transmission, online erschienen am 23.07.2026. Verfasst von Narumol Sukmueng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chulalongkorn Centre of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University…. Die Arbeit nennt 110 Literaturangaben. Gefördert von: Thailand Science Research and Innovation, Thailand Center for Excellence for Life Sciences, National Research Council of Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Levodopa remains the cornerstone of Parkinson’s disease (PD) treatment; however, long-term use is associated with motor complications, including fluctuations and dyskinesia. Non-motor symptoms also worsen over time, reflecting both disease progression and treatment-related effects. These limitations have prompted interest in plant-derived therapies as potential adjunctive options, although clinical evidence remains unclear. To systematically review clinical evidence on plant-derived therapies in PD, focusing on motor symptoms, non-motor symptoms, and motor complications. PubMed, Scopus, and ScienceDirect were searched to identify eligible studies assessing plant-derived therapies for PD. Risk of bias and evidence classification were assessed using established methods. The review followed PRISMA 2020 guidelines and was registered in PROSPERO (CRD420261276805). Twenty-three included studies evaluated six plant-derived therapies. Mucuna pruriens was supported by Grade A evidence for motor improvement, with benefits comparable to levodopa and increased ON time without worsening dyskinesia. It also reduced dyskinesia (Grade B). Apium graveolens improved motor symptoms, sleep, and quality of life (Grade B). Curcuma longa improved autonomic and non-motor symptoms (Grade C). Bacopa monnieri improved emotional symptoms (Grade B). Glycine max increased ON time and reduced dyskinesia (Grade C). Cannabis sativa showed no motor benefit (Grade A), with inconclusive non-motor outcomes. Selected plant-derived therapies may offer symptom-specific benefits in PD. However, the available evidence is limited, and grading reflects study hierarchy rather than the certainty of clinical effect. Therefore, interpretation of this information should be cautious. Larger, well-designed randomised trials are required to confirm efficacy and safety.

Schlagwörter

Stichwörter der Autor:innen

Motor complicationsNon-motor symptomsParkinson’s diseasePhytotherapyPlant-derived therapies

Autor:innen und Institutionen

  • Chulalongkorn Centre of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, 187…
  • The Academy of Science, The Royal Society of Thailand, Bangkok, 10330, Thailand. rbh@chulapd.org.

ORCID-Profile: Roongroj Bhidayasiri

Förderung

  • Thailand Science Research and Innovation
  • Thailand Center for Excellence for Life Sciences
  • National Research Council of Thailand
  • Chulalongkorn University

Zitieren

APA

Sukmueng, N., Phokaewvarangkul, O., & Bhidayasiri, R. (2026). Plant-derived therapies in Parkinson’s disease: a systematic review of clinical evidence. Journal of Neural Transmission. https://doi.org/10.1007/s00702-026-03239-4

Vancouver

Sukmueng N, Phokaewvarangkul O, Bhidayasiri R. Plant-derived therapies in Parkinson’s disease: a systematic review of clinical evidence. Journal of Neural Transmission. 2026. doi:10.1007/s00702-026-03239-4

BibTeX
@article{Sukmueng2026,
  author = {Sukmueng, Narumol and Phokaewvarangkul, Onanong and Bhidayasiri, Roongroj},
  title = {Plant-derived therapies in Parkinson’s disease: a systematic review of clinical evidence},
  journal = {Journal of Neural Transmission},
  year = {2026},
  doi = {10.1007/s00702-026-03239-4}
}
Kostenlos starten →